Virtual: Biobank and biomarker workshop

What is the optimal biomarker?
Welcome to a workshop to evaluate and define the optimal biomarkers for risk prediction and early detection of disease.
The invitation is open to all interested researchers at Umeå University.

Tid: 20 april 09:00 - 16:00

Plats: Virtual meeting

Med anledning av det rådande läget kring Coronaviruset kommer mötet att genomföras virituellt och endast den 20 april.

The meeting will be conducted virtual on Zoom, April 20.

Sista anmälningsdag är 8 april.

Deadline for registration is April 8, 2020

Länk till Zoom-möte kommer att skickas ut under vecka 16 till samtliga anmälda.


Workshop on biomarkers and omics technologies that potentially could be tested in our biobank cohorts.

09.00–09.10 Introduction. Beatrice Melin and Elin Thysell

09.15–09.45 Integrative analysis of lung cancer etiology and risk.

Mattias Johansson, International Agency for Research on Cancer (IARC), Lyon, France

09.45–10.00 Coffee break

10.00–10.30 Northern Sweden cohorts – unique possibilities for personalized screening and risk prediction for early detection of disease.

Stefan Söderberg, Department of Public Health and Clinical Medicine, Umeå University

10.40–11.40 Technical presentations and discussion.

Scilife lab

Opportunities at the SNP&SEQ Technology Platform and Plasma Profiling Facility.

Olink Proteomics

Precision proteomics by validated, high-throughput multiplexed assays for protein biomarker discovery.


Precision Metabolomics by liquid chromatography – mass spectrometry (LC-MS) technology for assessing health, wellness and disease.

11.40–12.30 Lunch

12.30–13.30 Technical reports and examples cont….


Actionable health information based on measuring thousands of proteins in a single sample by aptamer technology.


A new health-creation system – personalized and comprehensive health data based on your blood, so that you can understand how your lifestyle affects your body.

Thermo Fisher

Applied Biosystem Axiom Biobank Genotyping Solution for large-scale genotyping studies.

13.30–13.45 Coffee

13.45–14.00 What factors are to be considered for an optimal biomarker? Bethany van Guelpen

14.00–14.30 ZOOM breakout session from the current presentations – What is the optimal biomarker?

What additional risk factors do we not have in our cohort?

Discussion leaders in each group: Beatrice Melin, Elin Thysell, Ingvar Bergdahl, Mikael Johansson, Bethany van Guelpen

14.30–15.30 Full group discussion and ranking of factors especially important for our cohort. Beatrice Melin

15.30 End of a long Zoom meeting!